Document Detail

Mild metabolic abnormalities, abdominal obesity and the risk of cardiovascular diseases in middle-aged Japanese men.
MedLine Citation:
PMID:  20610894     Owner:  NLM     Status:  In-Process    
AIM: We investigated the individual and population impacts of mild abnormalities associated with metabolic syndrome (blood pressure, lipids and glucose) and abdominal obesity, for which lifestyle modification is initially applicable, on cardiovascular disease risk.
METHODS: Using a cohort study of 2,685 Japanese men aged 35 to 59 years with an 11-year follow-up period, we calculated the relative risks for cardiovascular diseases due to mild metabolic abnormalities that included at least one of the following three conditions: 1) systolic blood pressure 130-139 mmHg and/or diastolic blood pressure 85-89 mmHg; 2) triglycerides 150-299 mg/dL and/or high-density lipoprotein cholesterol 35-39 mg/dL; and 3) fasting plasma glucose 110-125 mg/dL and/or abdominal obesity. Participants with a mild metabolic abnormality were compared to participants with no metabolic abnormality or abdominal obesity. The population attributable fraction of these abnormalities for cardiovascular diseases was also estimated.
RESULTS: At baseline, 9.8% and 21.8% of the total population had a mild metabolic abnormality with or without abdominal obesity, respectively, while 7.5% had isolated abdominal obesity without any metabolic abnormality. A mild metabolic abnormality with or without abdominal obesity and isolated abdominal obesity increased the risk of cardiovascular disease by 2.68-fold, 1.49-fold, and 2.36-fold, respectively. Approximately 20% of cardiovascular diseases in the total population were attributable to either mild metabolic abnormalities or isolated abdominal obesity.
CONCLUSION: The importance of lifestyle modification should be acknowledged, especially in cases of mild metabolic abnormality and/or abdominal obesity, which may contribute to approximately 20% of the population burden for cardiovascular diseases.
Wataru Hirokawa; Koshi Nakamura; Masaru Sakurai; Yuko Morikawa; Katsuyuki Miura; Masao Ishizaki; Katsushi Yoshita; Teruhiko Kido; Yuchi Naruse; Hideaki Nakagawa
Related Documents :
21072494 - Metabolic profile of chronic liver disease by nmr spectroscopy of human biopsies.
2030254 - Hypothesis: increased calcium and decreased magnesium in heart muscle and liver of pigs...
22381334 - In vitro and in vivo metabolism and pharmacokinetics of bms-562086, a potent and orally...
21745594 - Changes of glycogen metabolism in the gills and hepatic tissue of tilapia (oreochromis ...
19383774 - A single nucleotide polymorphism on exon-4 of the gene encoding ppardelta is associated...
4019474 - Metabolic studies of pyruvate- and lactate-perfused guinea pig hearts by 13c nmr. deter...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-07-02
Journal Detail:
Title:  Journal of atherosclerosis and thrombosis     Volume:  17     ISSN:  1880-3873     ISO Abbreviation:  J. Atheroscler. Thromb.     Publication Date:  2010 Sep 
Date Detail:
Created Date:  2010-10-06     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9506298     Medline TA:  J Atheroscler Thromb     Country:  Japan    
Other Details:
Languages:  eng     Pagination:  934-43     Citation Subset:  IM    
Department of Epidemiology and Public Health, Kanazawa Medical University, Uchinada, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Therapeutic efficacy of continuous positive airway pressure in obstructive sleep apnea patients with...
Next Document:  Identification of evidence suggestive of an association with peripheral arterial disease at the OSBP...